Tertiary Prevention of HCC in Chronic Hepatitis B or C Infected Patients
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tertiary Prevention of HCC in Chronic Hepatitis B or C Infected Patients
Authors
Keywords
-
Journal
Cancers
Volume 13, Issue 7, Pages 1729
Publisher
MDPI AG
Online
2021-04-06
DOI
10.3390/cancers13071729
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hepatitis Flare During Immunotherapy in Patients With Current or Past Hepatitis B Virus Infection
- (2021) Grace Lai-Hung Wong et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Pathologic Predictive Factors for Late Recurrence of Hepatocellular Carcinoma in Chronic Liver Disease
- (2021) Ji Hae Nahm et al. LIVER INTERNATIONAL
- Partial abrogation of FXR-KNG1 signaling by carboxyl-terminal truncated HBx-C30 in hepatitis B virus-associated hepatocellular carcinoma
- (2021) Yongdong Niu et al. VIRUS RESEARCH
- Hepatitis B Virus Covalently Closed Circular DNA Predicts Postoperative Liver Cancer Metastasis Independent of Virological Suppression
- (2021) Chao-Wei Hsu et al. Cancers
- Advances in resection and transplantation for hepatocellular carcinoma
- (2020) Eric Vibert et al. JOURNAL OF HEPATOLOGY
- Safety and efficacy of immune checkpoint inhibitors in patients with non-small cell lung cancer and hepatitis B or hepatitis C infection
- (2020) Ana Pertejo-Fernandez et al. LUNG CANCER
- Cell‐free virus‐host chimera DNA from Hepatitis B virus integration sites as a circulating biomarker of hepatocellular cancer
- (2020) Chiao‐Ling Li et al. HEPATOLOGY
- Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
- (2020) Richard S. Finn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Conceptual Model for the Hepatocellular Carcinoma Screening Continuum: Current Status and Research Agenda
- (2020) Amit G. Singal et al. Clinical Gastroenterology and Hepatology
- Does Hepatocellular Carcinoma Surveillance Increase Survival in At-Risk Populations? Patient Selection, Biomarkers, and Barriers
- (2020) Lisa X. Deng et al. DIGESTIVE DISEASES AND SCIENCES
- Tenofovir vs entecavir on post-operative recurrence-free and overall survival of patients with hepatitis B virus-related hepatocellular carcinoma
- (2020) Jonggi Choi et al. JOURNAL OF HEPATOLOGY
- Risk of HBV reactivation in patients with immune checkpoint inhibitor-treated unresectable hepatocellular carcinoma
- (2020) Pei-Chang Lee et al. Journal for ImmunoTherapy of Cancer
- Direct-Acting Antiviral Therapy not Associated with Recurrence of Hepatocellular Carcinoma in a Multicenter North American Cohort Study
- (2019) Amit G. Singal et al. GASTROENTEROLOGY
- Predictors of hepatocellular carcinoma recurrence associated with the use of direct‐acting antiviral agent therapy for hepatitis C virus after curative treatment: A prospective multicenter cohort study
- (2019) Masahito Nakano et al. Cancer Medicine
- HCV-induced Epigenetic Changes Associated With Liver Cancer Risk Persist After Sustained Virologic Response
- (2019) Nourdine Hamdane et al. GASTROENTEROLOGY
- AGA Clinical Practice Update on Interaction between Oral Direct-Acting Antivirals (DAAs) for Chronic Hepatitis C Infection and Hepatocellular Carcinoma: Expert Review
- (2019) Amit G. Singal et al. GASTROENTEROLOGY
- What Comes First: Treatment of Viral Hepatitis or Liver Cancer?
- (2019) Jordan J. Feld et al. DIGESTIVE DISEASES AND SCIENCES
- Direct acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients
- (2019) Giuseppe Cabibbo et al. JOURNAL OF HEPATOLOGY
- Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial
- (2019) Richard S. Finn et al. JOURNAL OF CLINICAL ONCOLOGY
- Peg‐interferon and nucleos(t)ide analogue combination at inception of antiviral therapy improves both anti‐HBV efficacy and long‐term survival among HBV DNA‐positive hepatocellular carcinoma patients after hepatectomy/ablation
- (2019) Wenqian Qi et al. JOURNAL OF VIRAL HEPATITIS
- Interferon Is Superior to Direct Acting Antiviral Therapy in Tertiary Prevention of Early Recurrence of Hepatocellular Carcinoma
- (2019) Wei Teng et al. Cancers
- Systematic review with meta-analysis: recurrence of hepatocellular carcinoma following direct-acting antiviral therapy
- (2018) N. Saraiya et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Annual Report to the Nation on the Status of Cancer, part I: National cancer statistics
- (2018) Kathleen A. Cronin et al. CANCER
- Esophageal varices are not predictive of patient prognosis after surgical resection of hepatocellular carcinoma
- (2018) Chung-Yu Chang et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Levels of Cytokines in Serum Associate With Development of Hepatocellular Carcinoma in Patients With HCV Infection Treated With Direct-Acting Antivirals
- (2018) Jose D. Debes et al. GASTROENTEROLOGY
- Liver Angiopoietin-2 is a key predictor of de novo or recurrent hepatocellular cancer after HCV direct-acting antivirals
- (2018) Francesca Faillaci et al. HEPATOLOGY
- Hepatitis B virus surface gene pre-S2 mutant as a high-risk serum marker for hepatoma recurrence after curative hepatic resection
- (2018) Chia-Jui Yen et al. HEPATOLOGY
- Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
- (2018) Norah A. Terrault et al. HEPATOLOGY
- Direct-acting antivirals do not increase the risk of hepatocellular carcinoma recurrence after local-regional therapy or liver transplant waitlist dropout
- (2018) Annsa C. Huang et al. HEPATOLOGY
- Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan
- (2018) Sheng-Nan Lu et al. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
- Entecavir and tenofovir reduce hepatitis B virus-related hepatocellular carcinoma recurrence more effectively than other antivirals
- (2018) H. Cho et al. JOURNAL OF VIRAL HEPATITIS
- Increased recurrence rates of hepatocellular carcinoma after DAA therapy in a hepatitis C-infected Egyptian cohort: A comparative analysis
- (2018) M. El Kassas et al. JOURNAL OF VIRAL HEPATITIS
- Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
- (2018) Andrew X Zhu et al. LANCET ONCOLOGY
- Does interferon-free direct-acting antiviral therapy for hepatitis C after curative treatment for hepatocellular carcinoma lead to unexpected recurrences of HCC? A multicenter study by the Japanese Red Cross Hospital Liver Study Group
- (2018) Toshie Mashiba et al. PLoS One
- Preoperative Visceral Adiposity and Muscularity Predict Poor Outcomes after Hepatectomy for Hepatocellular Carcinoma
- (2018) Yuhei Hamaguchi et al. Liver Cancer
- Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection
- (2018) Anthony W.H. Chan et al. JOURNAL OF HEPATOLOGY
- Status of Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection and Remaining Challenges
- (2018) Thomas F. Baumert et al. GASTROENTEROLOGY
- Molecular Mechanisms Involved in HCC Recurrence after Direct-Acting Antiviral Therapy
- (2018) Rosanna Villani et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Role of liver and spleen stiffness in predicting the recurrence of hepatocellular carcinoma after resection
- (2018) Giovanni Marasco et al. JOURNAL OF HEPATOLOGY
- Impact of direct-acting antivirals on early recurrence of HCV-related HCC: Comparison with interferon-based therapy
- (2018) Mizuki Nishibatake Kinoshita et al. JOURNAL OF HEPATOLOGY
- HBsAg seroclearance further reduces hepatocellular carcinoma risk after complete viral suppression with nucleos(t)ide analogues
- (2018) Terry Cheuk-Fung Yip et al. JOURNAL OF HEPATOLOGY
- The impact of interferon-free direct-acting antivirals on clinical outcome after curative treatment for hepatitis C virus-associated hepatocellular carcinoma: Comparison with interferon-based therapy
- (2018) Yuko Nagaoki et al. JOURNAL OF MEDICAL VIROLOGY
- Taiwan consensus statement on the management of chronic hepatitis B
- (2018) Rong-Nan Chien et al. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
- Timely eradication of HCV viremia by PegIFN/RBV is crucial in prevention of post RFA recurrence in CHC-HCC patients
- (2018) Ying-Chieh Chen et al. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
- The impact of currently licensed therapies on viral and immune responses in chronic hepatitis B: Considerations for future novel therapeutics
- (2018) Upkar S. Gill et al. JOURNAL OF VIRAL HEPATITIS
- Imaging for the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis
- (2017) Lewis R. Roberts et al. HEPATOLOGY
- Impact of etiological treatment on prognosis
- (2017) Chien-Wei Su et al. Hepatology International
- Tricking the balance: NK cells in anti-cancer immunity
- (2017) Jens Pahl et al. IMMUNOBIOLOGY
- Hepatocellular carcinoma recurrence after direct antiviral agent treatment: A European multicentre study
- (2017) Philippe Kolly et al. JOURNAL OF HEPATOLOGY
- Increased peripheral CD4 + regulatory T cells persist after successful direct-acting antiviral treatment of chronic hepatitis C
- (2017) Bettina Langhans et al. JOURNAL OF HEPATOLOGY
- Effectiveness, safety and clinical outcomes of direct-acting antiviral therapy in HCV genotype 1 infection: Results from a Spanish real-world cohort
- (2017) Jose Luis Calleja et al. JOURNAL OF HEPATOLOGY
- Effect of interferon-based and -free therapy on early occurrence and recurrence of hepatocellular carcinoma in chronic hepatitis C
- (2017) Hiroko Nagata et al. JOURNAL OF HEPATOLOGY
- Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: A systematic review, meta-analyses, and meta-regression
- (2017) Reem Waziry et al. JOURNAL OF HEPATOLOGY
- Effectiveness of hepatitis C antiviral treatment in a USA cohort of veteran patients with hepatocellular carcinoma
- (2017) Lauren A. Beste et al. JOURNAL OF HEPATOLOGY
- Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma
- (2017) Giuseppe Cabibbo et al. JOURNAL OF HEPATOLOGY
- Hepatocellular carcinoma decreases the chance of successful hepatitis C virus therapy with direct-acting antivirals
- (2017) Stacey B. Prenner et al. JOURNAL OF HEPATOLOGY
- Is the risk of neoplastic recurrence increased after prescribing direct-acting antivirals for HCV patients whose HCC was previously cured?
- (2017) Claudio Zavaglia et al. JOURNAL OF HEPATOLOGY
- Expression of a hepatitis B virus pre-S2 deletion mutant in the liver results in hepatomegaly and hepatocellular carcinoma in mice
- (2017) Yuan-Chi Teng et al. JOURNAL OF PATHOLOGY
- Eradication of hepatitis C virus profoundly prolongs survival in hepatocellular carcinoma patients receiving transarterial chemoembolization
- (2017) W. Teng et al. JOURNAL OF VIRAL HEPATITIS
- The risk of early occurrence and recurrence of hepatocellular carcinoma in hepatitis C-infected patients treated with direct-acting antivirals with and without pegylated interferon: A Belgian experience
- (2017) R. Bielen et al. JOURNAL OF VIRAL HEPATITIS
- Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
- (2017) Anthony B El-Khoueiry et al. LANCET
- Direct-acting antiviral therapy decreases hepatocellular carcinoma recurrence rate in cirrhotic patients with chronic hepatitis C
- (2017) Victor Virlogeux et al. LIVER INTERNATIONAL
- Hepatocellular Carcinoma: Nomograms Based on the Albumin-Bilirubin Grade to Assess the Outcomes of Radiofrequency Ablation
- (2017) Wei-Yu Kao et al. RADIOLOGY
- The effect of antiviral therapy on patients with hepatitis B virus-related hepatocellular carcinoma after curative resection: a systematic review and meta-analysis
- (2017) Xu-Xiao Chen et al. OncoTargets and Therapy
- On-treatment decrease of NKG2D correlates to early emergence of clinically evident hepatocellular carcinoma after interferon-free therapy for chronic hepatitis C
- (2017) Po-sung Chu et al. PLoS One
- Oral nucleos(t)ide analogues reduce recurrence and death in chronic hepatitis B-related hepatocellular carcinoma
- (2016) G. L.-H. Wong et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon
- (2016) S. Petta et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Reduction of chronic hepatitis B-related hepatocellular carcinoma with anti-viral therapy, including low risk patients
- (2016) D. Lin et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- All-oral direct-acting antiviral therapy in HCV-advanced liver disease is effective in real-world practice: observations through HCV-TARGET database
- (2016) K. R. Reddy et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Nonreversible MAIT cell-dysfunction in chronic hepatitis C virus infection despite successful interferon-free therapy
- (2016) Julia Hengst et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Impact of sustained viral response postcurative therapy of hepatitis C-related hepatocellular carcinoma: a systematic review and meta-analysis
- (2016) Sashidhar Manthravadi et al. INTERNATIONAL JOURNAL OF CANCER
- Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals
- (2016) Fabio Conti et al. JOURNAL OF HEPATOLOGY
- The impact of direct-acting antivirals on early tumor recurrence after radiofrequency ablation in hepatitis C-related hepatocellular carcinoma
- (2016) Tatsuya Minami et al. JOURNAL OF HEPATOLOGY
- Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy
- (2016) María Reig et al. JOURNAL OF HEPATOLOGY
- Impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosis
- (2016) Graham R. Foster et al. JOURNAL OF HEPATOLOGY
- Outcomes after successful direct-acting antiviral therapy for patients with chronic hepatitis C and decompensated cirrhosis
- (2016) Michelle C.M. Cheung et al. JOURNAL OF HEPATOLOGY
- Lack of evidence of an effect of direct-acting antivirals on the recurrence of hepatocellular carcinoma: Data from three ANRS cohorts
- (2016) JOURNAL OF HEPATOLOGY
- Regression of fibrosis and portal hypertension in HCV-associated cirrhosis and sustained virologic response after interferon-free antiviral therapy
- (2016) V. Knop et al. JOURNAL OF VIRAL HEPATITIS
- Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients
- (2016) Tung-Hung Su et al. LIVER INTERNATIONAL
- Global epidemiology and burden of HCV infection and HCV-related disease
- (2016) Aaron P. Thrift et al. Nature Reviews Gastroenterology & Hepatology
- TERT promoter mutations in primary liver tumors
- (2016) Jean-Charles Nault et al. Clinics and Research in Hepatology and Gastroenterology
- Antiviral Therapy Improves Postoperative Survival in Patients With Hepatocellular Carcinoma
- (2015) Gang Huang et al. ANNALS OF SURGERY
- Successful Interferon-Free Therapy of Chronic Hepatitis C Virus Infection Normalizes Natural Killer Cell Function
- (2015) Elisavet Serti et al. GASTROENTEROLOGY
- The role of hepatic resection in the treatment of hepatocellular cancer
- (2015) Sasan Roayaie et al. HEPATOLOGY
- Association between nucleos(t)ide analog and tumor recurrence in hepatitis B virus-related hepatocellular carcinoma after radiofrequency ablation
- (2015) Teng-Yu Lee et al. HEPATOLOGY
- Effects of long-term entecavir treatment on the incidence of hepatocellular carcinoma in chronic hepatitis B patients
- (2015) Takao Watanabe et al. Hepatology International
- Sustained virologic response achieved after curative treatment of hepatitis C virus-related hepatocellular carcinoma as an independent prognostic factor
- (2015) Naoya Kanogawa et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- The tertiary prevention of hepatocellular carcinoma in chronic hepatitis C patients
- (2015) Jee-Fu Huang et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Memory re-differentiation and reduced lymphocyte activation in chronic HCV-infected patients receiving direct-acting antivirals
- (2015) M. A. Burchill et al. JOURNAL OF VIRAL HEPATITIS
- Antiviral therapy improves post-hepatectomy survival in patients with hepatitis B virus-related hepatocellular carcinoma: a prospective-retrospective study
- (2014) C. C. N. Chong et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- HBV DNA and HBsAg Levels as Risk Predictors of Early and Late Recurrence after Curative Resection of HBV-related Hepatocellular Carcinoma
- (2014) Won Sohn et al. ANNALS OF SURGICAL ONCOLOGY
- High Levels of Hepatitis B Surface Antigen are Associated with Poorer Survival and Early Recurrence of Hepatocellular Carcinoma in Patients with Low Hepatitis B Viral Loads
- (2014) Wei-Ren Liu et al. ANNALS OF SURGICAL ONCOLOGY
- Impact of Steatosis on Prognosis of Patients with Early-Stage Hepatocellular Carcinoma After Hepatic Resection
- (2014) Chien-Wei Su et al. ANNALS OF SURGICAL ONCOLOGY
- Human Viral Oncogenesis: A Cancer Hallmarks Analysis
- (2014) Enrique A. Mesri et al. Cell Host & Microbe
- Association of Nucleos(t)ide Analogue Therapy With Reduced Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B—A Nationwide Cohort Study
- (2014) Chun-Ying Wu et al. GASTROENTEROLOGY
- Restoration of HCV-specific CD8+ T cell function by interferon-free therapy
- (2014) Bianca Martin et al. JOURNAL OF HEPATOLOGY
- Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma
- (2014) Yujin Hoshida et al. JOURNAL OF HEPATOLOGY
- Nucleot(s)ide Analogues for Hepatitis B Virus-Related Hepatocellular Carcinoma after Curative Treatment: A Systematic Review and Meta-Analysis
- (2014) Ping Sun et al. PLoS One
- Postoperative peg-interferon plus ribavirin is associated with reduced recurrence of hepatitis C virus-related hepatocellular carcinoma
- (2013) Yao-Chun Hsu et al. HEPATOLOGY
- Antiviral therapy after curative treatment of hepatitis B/C virus-related hepatocellular carcinoma: A systematic review of randomized trials
- (2013) Ping Sun et al. HEPATOLOGY RESEARCH
- Effect of Antiviral Treatment With Nucleotide/Nucleoside Analogs on Postoperative Prognosis of Hepatitis B Virus–Related Hepatocellular Carcinoma: A Two-Stage Longitudinal Clinical Study
- (2013) Jianhua Yin et al. JOURNAL OF CLINICAL ONCOLOGY
- The Influence of Hepatitis B Viral Load and Pre-S Deletion Mutations on Post-Operative Recurrence of Hepatocellular Carcinoma and the Tertiary Preventive Effects by Anti-Viral Therapy
- (2013) Chien-Wei Su et al. PLoS One
- Effect and Safety of Interferon for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
- (2013) Liping Zhuang et al. PLoS One
- Targeting CD28, CTLA-4 and PD-L1 Costimulation Differentially Controls Immune Synapses and Function of Human Regulatory and Conventional T-Cells
- (2013) Nahzli Dilek et al. PLoS One
- The Anticancer Face of Interferon Alpha (IFN-Alpha): From Biology to Clinical Results, with a Focus on Melanoma
- (2012) S. Pasquali et al. CURRENT MEDICINAL CHEMISTRY
- Association Between Nucleoside Analogues and Risk of Hepatitis B Virus–Related Hepatocellular Carcinoma Recurrence Following Liver Resection
- (2012) Chun-Ying Wu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Hepatitis C viral protein NS5A induces EMT and participates in oncogenic transformation of primary hepatocyte precursors
- (2012) Leila Akkari et al. JOURNAL OF HEPATOLOGY
- Efficacy of pegylated interferon alpha-2b and ribavirin treatment on the risk of hepatocellular carcinoma in patients with chronic hepatitis C: A prospective, multicenter study
- (2012) Eiichi Ogawa et al. JOURNAL OF HEPATOLOGY
- Hepatocellular carcinoma
- (2012) Alejandro Forner et al. LANCET
- Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study
- (2012) Patrick Marcellin et al. LANCET
- Fine mapping of hepatitis B virus pre-S deletion and its association with hepatocellular carcinoma
- (2012) Jia-Horng Kao et al. LIVER INTERNATIONAL
- Radiofrequency Ablation for Hepatocellular Carcinoma: 10-Year Outcome and Prognostic Factors
- (2011) Shuichiro Shiina et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Long-Term Results of a Randomized, Observation-Controlled, Phase III Trial of Adjuvant Interferon Alfa-2b in Hepatocellular Carcinoma After Curative Resection
- (2011) Li-Tzong Chen et al. ANNALS OF SURGERY
- Impact of Antiviral Therapy on the Survival of Patients After Major Hepatectomy for Hepatitis B Virus–Related Hepatocellular Carcinoma
- (2011) Albert C. Y. Chan ARCHIVES OF SURGERY
- The Effect of Age on the Long-term Prognosis of Patients With Hepatocellular Carcinoma After Resection Surgery
- (2011) Chien-Wei Su ARCHIVES OF SURGERY
- Emergence of the rtA181T/sW172* mutant increased the risk of hepatoma occurrence in patients with lamivudine-resistant chronic hepatitis B
- (2011) Chau-Ting Yeh et al. BMC CANCER
- Systematic review and meta-analysis of survival and disease recurrence after radiofrequency ablation for hepatocellular carcinoma
- (2011) L. Tiong et al. BRITISH JOURNAL OF SURGERY
- Aberrant cyclin A expression and centrosome overduplication induced by hepatitis B virus Pre-S2 mutants and its implication in hepatocarcinogenesis
- (2011) L. H.-C. Wang et al. CARCINOGENESIS
- Hepatitis B virus X gene and hepatocarcinogenesis
- (2011) Sue-Ann Ng et al. JOURNAL OF GASTROENTEROLOGY
- Forecasting the morbidity and mortality associated with prevalent cases of pre-cirrhotic chronic hepatitis C in the United States☆☆☆
- (2010) David B. Rein et al. DIGESTIVE AND LIVER DISEASE
- Interferon-α therapy after curative resection prevents early recurrence and improves survival in patients with hepatitis B virus-related hepatocellular carcinoma
- (2010) Li-Shuai Qu et al. JOURNAL OF SURGICAL ONCOLOGY
- Risk factors for early and late recurrence in hepatitis B-related hepatocellular carcinoma
- (2009) Jaw-Ching Wu et al. JOURNAL OF HEPATOLOGY
- Recurrence of Hepatitis B-Related Hepatocellular Carcinoma Is Associated With High Viral Load at the Time of Resection
- (2008) Ivan F. N. Hung et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Combined Mutations in Pre‐S/Surface and Core Promoter/Precore Regions of Hepatitis B Virus Increase the Risk of Hepatocellular Carcinoma: A Case-Control Study
- (2008) Chien‐Hung Chen et al. JOURNAL OF INFECTIOUS DISEASES
- Associations Between Hepatitis B Virus Genotype and Mutants and the Risk of Hepatocellular Carcinoma
- (2008) H.-I. Yang et al. JNCI-Journal of the National Cancer Institute
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started